Biblio Discovery — Demo Discovery Service

18 hasil

Menampilkan 1–18 · 0,49 detik · RSS

Jurnal

Nature Structural & Molecular Biology

Scopus

ISSN 1545-9985 · Nature Portfolio · 18 artikel di indeks

  1. Artikel Jurnal Teks lengkap

    Towards a structurally resolved human protein interaction network

    David F. Burke; Patrick Bryant; Inigo Barrio‐Hernandez dkk.

    Nature Structural & Molecular Biology · 2023 · Inggris · OpenAlex Scopus

    Cellular functions are governed by molecular machines that assemble through protein-protein interactions. Their atomic details are critical to studying their molecular mechanisms. However, fewer than 5% of hundreds of thousands of human protein interactions have been structurally characterized…

  2. Artikel Jurnal Teks lengkap

    A structural biology community assessment of AlphaFold2 applications

    Mehmet Akdel; Douglas E. V. Pires; Eduard Porta‐Pardo dkk.

    Nature Structural & Molecular Biology · 2022 · Inggris · OpenAlex Scopus

    Most proteins fold into 3D structures that determine how they function and orchestrate the biological processes of the cell. Recent developments in computational methods for protein structure predictions have reached the accuracy of experimentally determined models. Although this has been…

  3. Artikel Jurnal Teks lengkap

    GPCR activation mechanisms across classes and macro/microscales

    Alexander S. Hauser; Albert J. Kooistra; Christian Munk dkk.

    Nature Structural & Molecular Biology · 2021 · Inggris · OpenAlex Scopus

    Two-thirds of human hormones and one-third of clinical drugs activate ~350 G-protein-coupled receptors (GPCR) belonging to four classes: A, B1, C and F. Whereas a model of activation has been described for class A, very little is known about the activation of the other classes, which differ by…

  4. Artikel Jurnal Teks lengkap

    Mechanism of molnupiravir-induced SARS-CoV-2 mutagenesis

    Florian Kabinger; Carina Stiller; Jana Schmitzová dkk.

    Nature Structural & Molecular Biology · 2021 · Inggris · OpenAlex Scopus

    Abstract Molnupiravir is an orally available antiviral drug candidate currently in phase III trials for the treatment of patients with COVID-19. Molnupiravir increases the frequency of viral RNA mutations and impairs SARS-CoV-2 replication in animal models and in humans. Here, we establish the…